Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Multiple sclerosis
•
Neurology
•
Neuro-immunology
How do you decide between escalation to a high efficacy DMT versus switching to a different moderate efficacy DMT in patients with poorly controlled multiple sclerosis?
Related Questions
When should patients be referred for advanced MRI testing to assess for CVS and PRL?
What are best practices to avoid misdiagnosis of multiple sclerosis in patients over 50 years old?
At what degree of lymphopenia do you switch/discontinue dimethyl fumarate in patients with multiple sclerosis?
Which patients will have earlier diagnosis of multiple sclerosis via the new 2024 McDonald Criteria?
What are potential pitfalls in the use of OCT to support a diagnosis of multiple sclerosis?
How do you interpret conflicting findings on CSF immunoglobulin tests for work up of multiple sclerosis and its mimics?
What are your vaccine recommendations while patients are on biologics?
How do you counsel women on anti-CD20 therapy for MS who are planning for pregnancy?
What therapy do you recommend in situations where IV steroids and IVIg do not help patients with GABA-A encephalitis?
When would you use ofatumumab for anti-NMDAR autoimmune encephalitis?
